We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for real-time alerts, custom portfolio, and market movers
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| E-therapeutics Plc | LSE:ETX | London | Ordinary Share | GB00B2823H99 | ORD 0.1P |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.15 | 1.69% | 9.00 | 9.00 | 9.45 | 9.05 | 8.80 | 8.85 | 1,316,188 | 12:07:29 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| Coml Physical, Biologcl Resh | 475k | -8.27M | -0.0142 | -6.34 | 52.55M |
From Apr 2019 to Apr 2024
TIDMETX
RNS Number : 6153Z
e-Therapeutics plc
18 December 2017
E-THERAPEUTICS PLC
("e-therapeutics" or the "Company")
NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PERSONS
DISCHARGING MANAGERIAL RESPONSIBILITIES
Oxford, UK, 18 December 2017: e-therapeutics plc (AIM: ETX), the computer-based drug discovery platform company, announces that it has received notifications from each of its directors that they have purchased, in aggregate, 670,000 shares in the Company at a price of 8.9 pence per share. The purchases took place on 15 December 2017.
The number of ordinary shares purchased by each director is set out below:
Hot Features
Premium
Director Number
of shares
purchased
------------------ -----------
Iain Ross 200,000
------------------ -----------
Ray Barlow 100,000
------------------ -----------
Steve Medlicott 200,000
------------------ -----------
Professor Trevor
Jones 50,000
------------------ -----------
Christine Soden 120,000
------------------ -----------
Mr Medlicott purchased the shares through his self-invested personal pension (SIPP) and, following these trades, the beneficial interests of those directors in ordinary shares of ETX are as follows:
Director Number of Percentage
shares held of issued
share capital
----------------- ------------- ---------------
Iain Ross 1,450,000 0.54%
----------------- ------------- ---------------
Ray Barlow 1,200,000 0.45%
----------------- ------------- ---------------
Steve Medlicott 1,450,000 0.54%
----------------- ------------- ---------------
Professor
Trevor Jones 262,261 0.10%
----------------- ------------- ---------------
Christine
Soden 120,000 0.04%
----------------- ------------- ---------------
The notifications below, made in accordance with the requirements of the EU Market Abuse Regulation, provide further details:
1 Details of the person discharging managerial
responsibilities/person closely associated
--- -------------------------------------------------------------
a) Name Iain Ross
--- ------------------------ -----------------------------------
2 Reason for the notification
--- -------------------------------------------------------------
a) Position/status Non-Executive Chairman
--- ------------------------ -----------------------------------
b) Initial notification/ Initial notification
Amendment
--- ------------------------ -----------------------------------
3 Details of the issuer, emission allowance market
participant, auction platform, auctioneer or
auction monitor
--- -------------------------------------------------------------
a) Name e-therapeutics plc
--- ------------------------ -----------------------------------
b) LEI 21380049RHSSJXWKYT18
--- ------------------------ -----------------------------------
4 Details of the transaction(s): section to be
repeated for (i) each type of instrument; (ii)
each type of transaction; (iii) each date; and
(iv) each place where transactions have been
conducted
--- -------------------------------------------------------------
a) Description of Ordinary shares of 0.1 pence
the financial
instrument, type ISIN: GB00B2823H99
of instrument
Identification
code
--- ------------------------ -----------------------------------
b) Nature of the Purchase of shares
transaction
--- ------------------------ -----------------------------------
c) Price(s) and 200,000 ordinary shares at a price
volume(s) of 8.9 pence per share
--- ------------------------ -----------------------------------
d) Aggregated information N/A
- Aggregated
volume
- Price
--- ------------------------ -----------------------------------
e) Date of the transaction 15 December 2017
--- ------------------------ -----------------------------------
f) Place of the London Stock Exchange, AIM (XLON)
transaction
--- ------------------------ -----------------------------------
1 Details of the person discharging managerial
responsibilities/person closely associated
--- -------------------------------------------------------------
a) Name Ray Barlow
--- ------------------------ -----------------------------------
2 Reason for the notification
--- -------------------------------------------------------------
a) Position/status Chief Executive Officer/Director
--- ------------------------ -----------------------------------
b) Initial notification/ Initial notification
Amendment
--- ------------------------ -----------------------------------
3 Details of the issuer, emission allowance market
participant, auction platform, auctioneer or
auction monitor
--- -------------------------------------------------------------
a) Name e-therapeutics plc
--- ------------------------ -----------------------------------
b) LEI 21380049RHSSJXWKYT18
--- ------------------------ -----------------------------------
4 Details of the transaction(s): section to be
repeated for (i) each type of instrument; (ii)
each type of transaction; (iii) each date; and
(iv) each place where transactions have been
conducted
--- -------------------------------------------------------------
a) Description of Ordinary shares of 0.1 pence
the financial
instrument, type ISIN: GB00B2823H99
of instrument
Identification
code
--- ------------------------ -----------------------------------
b) Nature of the Purchase of shares
transaction
--- ------------------------ -----------------------------------
c) Price(s) and 100,000 ordinary shares at a price
volume(s) of 8.9 pence per share
--- ------------------------ -----------------------------------
d) Aggregated information N/A
- Aggregated
volume
- Price
--- ------------------------ -----------------------------------
e) Date of the transaction 15 December 2017
--- ------------------------ -----------------------------------
f) Place of the London Stock Exchange, AIM (XLON)
transaction
--- ------------------------ -----------------------------------
1 Details of the person discharging managerial
responsibilities/person closely associated
--- -------------------------------------------------------------------
a) Name Steve Medlicott
--- ------------------------ -----------------------------------------
2 Reason for the notification
--- -------------------------------------------------------------------
a) Position/status Chief Finance Officer/Director
--- ------------------------ -----------------------------------------
b) Initial notification/ Initial notification
Amendment
--- ------------------------ -----------------------------------------
3 Details of the issuer, emission allowance market
participant, auction platform, auctioneer or
auction monitor
--- -------------------------------------------------------------------
a) Name e-therapeutics plc
--- ------------------------ -----------------------------------------
b) LEI 21380049RHSSJXWKYT18
--- ------------------------ -----------------------------------------
4 Details of the transaction(s): section to be
repeated for (i) each type of instrument; (ii)
each type of transaction; (iii) each date; and
(iv) each place where transactions have been
conducted
--- -------------------------------------------------------------------
a) Description of Ordinary shares of 0.1 pence
the financial
instrument, type ISIN: GB00B2823H99
of instrument
Identification
code
--- ------------------------ -----------------------------------------
b) Nature of the Purchase of shares through self-invested
transaction personal pension (SIPP)
--- ------------------------ -----------------------------------------
c) Price(s) and 200,000 ordinary shares at a price
volume(s) of 8.9 pence per share
--- ------------------------ -----------------------------------------
d) Aggregated information N/A
- Aggregated
volume
- Price
--- ------------------------ -----------------------------------------
e) Date of the transaction 15 December 2017
--- ------------------------ -----------------------------------------
f) Place of the London Stock Exchange, AIM (XLON)
transaction
--- ------------------------ -----------------------------------------
1 Details of the person discharging managerial
responsibilities/person closely associated
--- ------------------------------------------------------------
a) Name Professor Trevor Jones
--- ------------------------ ----------------------------------
2 Reason for the notification
--- ------------------------------------------------------------
a) Position/status Non-Executive Director
--- ------------------------ ----------------------------------
b) Initial notification/ Initial notification
Amendment
--- ------------------------ ----------------------------------
3 Details of the issuer, emission allowance market
participant, auction platform, auctioneer or
auction monitor
--- ------------------------------------------------------------
a) Name e-therapeutics plc
--- ------------------------ ----------------------------------
b) LEI 21380049RHSSJXWKYT18
--- ------------------------ ----------------------------------
4 Details of the transaction(s): section to be
repeated for (i) each type of instrument; (ii)
each type of transaction; (iii) each date; and
(iv) each place where transactions have been
conducted
--- ------------------------------------------------------------
a) Description of Ordinary shares of 0.1 pence
the financial
instrument, type ISIN: GB00B2823H99
of instrument
Identification
code
--- ------------------------ ----------------------------------
b) Nature of the Purchase of shares
transaction
--- ------------------------ ----------------------------------
c) Price(s) and 50,000 ordinary shares at a price
volume(s) of 8.9 pence per share
--- ------------------------ ----------------------------------
d) Aggregated information N/A
- Aggregated
volume
- Price
--- ------------------------ ----------------------------------
e) Date of the transaction 15 December 2017
--- ------------------------ ----------------------------------
f) Place of the London Stock Exchange, AIM (XLON)
transaction
--- ------------------------ ----------------------------------
1 Details of the person discharging managerial
responsibilities/person closely associated
--- -------------------------------------------------------------
a) Name Christine Soden
--- ------------------------ -----------------------------------
2 Reason for the notification
--- -------------------------------------------------------------
a) Position/status Non-Executive Director
--- ------------------------ -----------------------------------
b) Initial notification/ Initial notification
Amendment
--- ------------------------ -----------------------------------
3 Details of the issuer, emission allowance market
participant, auction platform, auctioneer or
auction monitor
--- -------------------------------------------------------------
a) Name e-therapeutics plc
--- ------------------------ -----------------------------------
b) LEI 21380049RHSSJXWKYT18
--- ------------------------ -----------------------------------
4 Details of the transaction(s): section to be
repeated for (i) each type of instrument; (ii)
each type of transaction; (iii) each date; and
(iv) each place where transactions have been
conducted
--- -------------------------------------------------------------
a) Description of Ordinary shares of 0.1 pence
the financial
instrument, type ISIN: GB00B2823H99
of instrument
Identification
code
--- ------------------------ -----------------------------------
b) Nature of the Purchase of shares
transaction
--- ------------------------ -----------------------------------
c) Price(s) and 120,000 ordinary shares at a price
volume(s) of 8.9 pence per share
--- ------------------------ -----------------------------------
d) Aggregated information N/A
- Aggregated
volume
- Price
--- ------------------------ -----------------------------------
e) Date of the transaction 15 December 2017
--- ------------------------ -----------------------------------
f) Place of the London Stock Exchange, AIM (XLON)
transaction
--- ------------------------ -----------------------------------
For further information, please contact:
e-therapeutics plc Tel: +44 (0) 1993 Ray Barlow, Chief Executive 883 125 Officer www.etherapeutics.co.uk Steve Medlicott, Finance Director Numis Securities Limited Tel: +44 (0) 207 Michael Meade/Freddie Barnfield 260 1000 (Corporate Finance) www.numis.com James Black (Corporate Broking) Instinctif Partners Tel: +44 (0) 207 Melanie Toyne Sewell/Alex 457 2020 Shaw Email: e-therapeutics@instinctif.com
About e-therapeutics plc
We are an Oxford-based company with a unique and powerful computer-based drug discovery platform and a specialised approach to network biology.
Our novel methodology and our Discovery Engine allow us to discover new and better drugs in a more efficient and effective way.
e-therapeutics is headquartered in Oxford. For more information about the Company please visit www.etherapeutics.co.uk.
This information is provided by RNS
The company news service from the London Stock Exchange
END
DSHLIFETFRLTLID
(END) Dow Jones Newswires
December 18, 2017 03:57 ET (08:57 GMT)
1 Year E-therapeutics Chart |
1 Month E-therapeutics Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
